Myelodysplastic/Myeloproliferative Diseases [clinicaltrials_resource:53d65514bfa702d36cd75e0ea300a2a7]
Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders [clinicaltrials:NCT00002792]Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00002809]clinicaltrials:NCT00003116Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003243]clinicaltrials:NCT00003335clinicaltrials:NCT00003336clinicaltrials:NCT00003816Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease [clinicaltrials:NCT00003913]Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00003961]12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder [clinicaltrials:NCT00004058]Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00004871]Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00004896]Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00004899]Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00006042]Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer [clinicaltrials:NCT00006225]Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00006239]clinicaltrials:NCT00006379MS-275 in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00015925]Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer [clinicaltrials:NCT00036790]Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00044954]Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder [clinicaltrials:NCT00049634]Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia [clinicaltrials:NCT00052832]clinicaltrials:NCT00053287Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Aplastic Anemia [clinicaltrials:NCT00053989]clinicaltrials:NCT00054236clinicaltrials:NCT00054327Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder [clinicaltrials:NCT00054340]Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00062140]clinicaltrials:NCT00066248Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia [clinicaltrials:NCT00066417]Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies [clinicaltrials:NCT00068523]3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome [clinicaltrials:NCT00077558]Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients [clinicaltrials:NCT00082654]Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation [clinicaltrials:NCT00089037]Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes [clinicaltrials:NCT00093366]Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation [clinicaltrials:NCT00096096]clinicaltrials:NCT00109993Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes [clinicaltrials:NCT00217386]G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders [clinicaltrials:NCT00253552]Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer [clinicaltrials:NCT00255710]
condition [clinicaltrials_vocabulary:condition]
Myelodysplastic/Myeloproliferative Diseases [clinicaltrials_resource:53d65514bfa702d36cd75e0ea300a2a7]
Bio2RDF identifier
53d65514bfa702d36cd75e0ea300a2a7
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:53d65514bfa702d36cd75e0ea300a2a7
identifier
clinicaltrials_resource:53d65514bfa702d36cd75e0ea300a2a7
title
Myelodysplastic/Myeloproliferative Diseases
@en
label
Myelodysplastic/Myeloprolifera ...... 65514bfa702d36cd75e0ea300a2a7]
@en